Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Correvio Pharma Corp.

https://correvio.com/

Latest From Correvio Pharma Corp.

Deal Watch: Roche To Try Pieris’s Anticalins In Respiratory, Ophthalmic Indications

Pieris and Genentech try partnering again after a disappointing IO tie-up before. Biogen’s hectic May includes partnerships with Ginkgo, Envisagenics, Capsigen and an opt-in on TMS’s stroke candidate.

Deals Deal Watch

Neurocrine Not Giving Up On Luvadaxistat Despite Phase II Miss

Schizophrenia drug licensed from Takeda missed Phase II endpoint for negative symptoms, but hits secondary cognition endpoints. Neurocrine plans to further study compound for cognitive benefits.

Clinical Trials Drug Approval Standards

MedLumics Closes $21.7M Financing To Support Optically Guided Ablation Catheter

The Madrid, Spain-based company is developing the AblaView ablation catheter for treating atrial fibrillation.

Financing Cardiovascular

PTC Eyes Transition From Capital-Raising To Money-Making Company

With $1.1bn in cash plus revenue from its existing commercial products and royalties from Roche’s sales of newly approved Evrysdi to invest in R&D, PTC Therapeutics may achieve profitability in 2023.

Business Strategies Rare Diseases
See All

Company Information

  • Industry
  • Pharmaceuticals
    • Specialty Pharmaceuticals
  • Other Names / Subsidiaries
    • ADVANZ PHARMA Corp. Limited
    • Cardiome Pharma Corp. (CRME)
    • Cardiome Development AG
    • Correvio LLC (Iroko Cardio LLC)
UsernamePublicRestriction

Register